BIAD .22 Agreement with big pharma Sysmex. Small market cap of close to 9 million. Definitely undervalued. Hand held device that gives results of INR for patient on blood thinners (Coumadin). They also are working on other hand held devices for different diagnostic test (Troponin I). These test would save money and time. Could be huge.